ClinicalTrials.Veeva

Menu

Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)

Vanderbilt University logo

Vanderbilt University

Status

Invitation-only

Conditions

Nonalcoholic Fatty Liver Disease

Study type

Observational

Funder types

Other

Identifiers

NCT00983463
IRB #090657

Details and patient eligibility

About

Nonalcoholic fatty liver disease (NAFLD) is the most common type of liver disease in the United States. The incidence of NAFLD is very similar to that of obesity, type 2 diabetes, and the metabolic syndrome. The investigators hypothesize that there may be a relationship between over-nutrition, decreased physical activity and the development of fatty liver. The purpose of this study is to identify the types of fats and proteins, and the quantity of each, that are associated with increased severity of NAFLD.

Enrollment

45 estimated patients

Sex

Female

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18-65 year of age
  • Undergoing elective abdominal or bariatric surgery
  • May have normal or elevated ALT/AST levels

Exclusion criteria

  • Presence of viral hepatitis
  • Significant alcohol use
  • Intercurrent infections
  • Use of any thiazolidinediones

Trial design

45 participants in 3 patient groups

Obese, bariatric surgery, liver biopsy
Description:
Obese subjects approved and scheduled for bariatric surgery at Vanderbilt University Medical Center
Normal BMI, abdominal surgery, liver biopsy
Description:
Normal weight subjects having elective abdominal surgery at Vanderbilt University Medical Center.
Liver transplantation donors and recipients
Description:
All livers made available for implantation or explantation will be eligible.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems